Advanced Biomed Inc. Common Stock (ADVB) Financials

$0.75

$0.03 (-4.33%)
Last update: 04:00 PM EST
Day's range
$0.74
Day's range
$0.81

ADVB Income statement / Annual

Last year (2023), Advanced Biomed Inc. Common Stock's total revenue was $0.00, and the percentage change from the previous year is not available. In 2023, Advanced Biomed Inc. Common Stock's net income was -$2.78 M. See Advanced Biomed Inc. Common Stock,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020
Period Ended 06/30/2024 06/30/2023 06/30/2022 06/30/2021
Operating Revenue $0.00 $0.00 $0.00 $0.00
Cost of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Gross Profit Ratio 0 0 0 0
Research and Development Expenses $880.19 K $1.38 M $1.62 M $1.73 M
General & Administrative Expenses $1.26 M $1.32 M $624.77 K $44.47 K
Selling & Marketing Expenses $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $1.26 M $1.32 M $624.77 K $44.47 K
Other Expenses $399.60 K $365.23 K $130.07 K $57.85 K
Operating Expenses $2.54 M $3.07 M $2.37 M $1.84 M
Cost And Expenses $2.54 M $3.07 M $2.37 M $1.84 M
Interest Income $53.50 K $21.40 K $243.00 $28.00
Interest Expense $0.00 $0.00 $0.00 $0.00
Depreciation & Amortization $399.60 K $365.23 K $126.63 K $57.85 K
EBITDA -$2.14 M -$2.71 M -$2.24 M -$1.78 M
EBITDA Ratio 0 0 0 0
Operating Income Ratio 0 0 0 0
Total Other Income/Expenses Net -$240.71 K -$661.55 K -$1.65 M -$218.00
Income Before Tax -$2.78 M -$3.73 M -$4.03 M -$1.84 M
Income Before Tax Ratio 0 0 0 0
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Net Income -$2.78 M -$3.73 M -$4.03 M -$1.84 M
Net Income Ratio 0 0 0 0
EPS -0.14 -0.19 -0.28 -0.16
EPS Diluted -0.14 -0.19 -0.28 -0.16
Weighted Average Shares Out $20.00 M $19.94 M $14.18 M $11.46 M
Weighted Average Shares Out Diluted $20.00 M $19.94 M $14.18 M $11.46 M
Link